Catalent Company Profile (NASDAQ:CTLT)

About Catalent (NASDAQ:CTLT)

Catalent logoCatalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels. The Drug Delivery Solutions segment is engaged in the formulation, development and manufacturing of prescription and consumer and animal health products; blow-fill seal unit dose manufacturing; biologic cell line development; analytical and bioanalytical development, and testing services. The Clinical Supply Services segment is engaged in manufacturing, packaging, labeling, storage, distribution and inventory management for clinical trials of drugs and biologics for patient kits; FastChain clinical supply service; clinical e-solutions and informatics, and global comparator sourcing services.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Pharmaceuticals - NEC
  • Sub-Industry: N/A
  • Symbol: NASDAQ:CTLT
  • CUSIP: N/A
  • Web: www.catalent.com/
Capitalization:
  • Market Cap: $4.48 billion
  • Outstanding Shares: 124,960,000
Average Prices:
  • 50 Day Moving Avg: $36.41
  • 200 Day Moving Avg: $30.94
  • 52 Week Range: $21.83 - $38.73
P/E:
  • Trailing P/E Ratio: 42.23
  • Foreward P/E Ratio: 22.83
  • P/E Growth: 2.93
Sales & Book Value:
  • Annual Revenue: $1.99 billion
  • Price / Sales: 2.25
  • Book Value: $5.14 per share
  • Price / Book: 6.97
Profitability:
  • EBIDTA: $395.3 million
  • Net Margins: 4.88%
  • Return on Equity: 16.95%
  • Return on Assets: 3.24%
Misc:
  • Average Volume: 1.01 million shs.
  • Short Ratio: 2.94
 

Frequently Asked Questions for Catalent (NASDAQ:CTLT)

What is Catalent's stock symbol?

Catalent trades on the NASDAQ under the ticker symbol "CTLT."

How were Catalent's earnings last quarter?

Catalent Inc (NASDAQ:CTLT) announced its quarterly earnings results on Thursday, May, 4th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.02. The company earned $532.60 million during the quarter, compared to analysts' expectations of $470.95 million. Catalent had a return on equity of 16.95% and a net margin of 4.88%. Catalent's quarterly revenue was up 21.6% on a year-over-year basis. During the same period last year, the business earned $0.21 earnings per share. View Catalent's Earnings History.

When will Catalent make its next earnings announcement?

Catalent is scheduled to release their next quarterly earnings announcement on Monday, August, 28th 2017. View Earnings Estimates for Catalent.

Where is Catalent's stock going? Where will Catalent's stock price be in 2017?

8 brokers have issued 1 year price objectives for Catalent's stock. Their forecasts range from $25.00 to $38.00. On average, they anticipate Catalent's stock price to reach $30.83 in the next year. View Analyst Ratings for Catalent.

What are analysts saying about Catalent stock?

Here are some recent quotes from research analysts about Catalent stock:

  • 1. According to Zacks Investment Research, "Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment address the full diversity of the pharmaceutical industry including small molecules, large molecule biologics and consumer health products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. Catalent, Inc. is headquartered in Somerset, New Jersey. " (7/4/2017)
  • 2. Jefferies Group LLC analysts commented, "The promise of stability offered by CTLT's diversified revenue stream and LT contracts has been thwarted by FX headwinds, the Beinheim shutdown, and overstocking by DDS segment client. Currency movements are hard to predict or avoid, but management believes the latter two are history. Tuck-in M&A remains a focus to augment mid-single digit revenue growth. We increase estimates and PT slightly. Remain at Hold." (2/27/2017)

Who are some of Catalent's key competitors?

Who are Catalent's key executives?

Catalent's management team includes the folowing people:

  • John R. Chiminski, Chairman of the Board, President, Chief Executive Officer
  • Matthew M. Walsh CPA, Chief Financial Officer, Executive Vice President
  • Aristippos Gennadios, President - Softgel Technologies
  • Wetteny Joseph, President - Clinical Supply Services
  • Barry B. Littlejohns, President - Advanced Delivery Technologies
  • Steven L. Fasman, Senior Vice President, General Counsel and Corporate Secretary
  • William Downie, Senior Vice President - Global Marketing & Sales
  • Lance Miyamoto, Senior Vice President - Human Resources
  • Sharon Johnson, Senior Vice President - Quality, Product Development & Regulatory Affairs
  • Madhavan Balachandran, Director

Who owns Catalent stock?

Catalent's stock is owned by many different of retail and institutional investors. Top institutional shareholders include GW&K Investment Management LLC (1.34%), CWM LLC (0.07%), Bank of Montreal Can (0.07%), State Treasurer State of Michigan (0.04%), Oregon Public Employees Retirement Fund (0.04%) and Louisiana State Employees Retirement System (0.03%). Company insiders that own Catalent stock include Blackstone Management Associat, Donald E Morel, Jr, John R Chiminski, Matthew M Walsh and Sharon Johnson. View Institutional Ownership Trends for Catalent.

Who sold Catalent stock? Who is selling Catalent stock?

Catalent's stock was sold by a variety of institutional investors in the last quarter, including CWM LLC and Atria Investments LLC. Company insiders that have sold Catalent stock in the last year include Blackstone Management Associat, John R Chiminski and Sharon Johnson. View Insider Buying and Selling for Catalent.

Who bought Catalent stock? Who is buying Catalent stock?

Catalent's stock was bought by a variety of institutional investors in the last quarter, including GW&K Investment Management LLC, Bank of Montreal Can, Meeder Asset Management Inc., Legato Capital Management LLC, Fox Run Management L.L.C., Oregon Public Employees Retirement Fund, LS Investment Advisors LLC and Louisiana State Employees Retirement System. View Insider Buying and Selling for Catalent.

How do I buy Catalent stock?

Shares of Catalent can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Catalent's stock price today?

One share of Catalent stock can currently be purchased for approximately $35.85.


MarketBeat Community Rating for Catalent (NASDAQ CTLT)
Community Ranking:  2.1 out of 5 ( )
Outperform Votes:  108 (Vote Outperform)
Underperform Votes:  151 (Vote Underperform)
Total Votes:  259
MarketBeat's community ratings are surveys of what our community members think about Catalent and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Catalent (NASDAQ:CTLT) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Hold Ratings, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $30.83 (13.99% downside)

Analysts' Ratings History for Catalent (NASDAQ:CTLT)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/21/2017Bank of America CorporationReiterated RatingBuy$37.00 -> $38.00LowView Rating Details
5/15/2017William BlairUpgradeMarket Perform -> OutperformN/AView Rating Details
2/27/2017Jefferies Group LLCBoost Price TargetHold$29.00 -> $32.00N/AView Rating Details
12/1/2016Goldman Sachs Group, Inc. (The)Initiated CoverageNeutral$25.00N/AView Rating Details
10/20/2016KeyCorpInitiated CoverageOverweight$29.00N/AView Rating Details
10/18/2016StephensInitiated CoverageOverweight$31.00N/AView Rating Details
8/30/2016Piper Jaffray CompaniesReiterated RatingOverweight$30.50 -> $30.00N/AView Rating Details
8/30/2016Morgan StanleyReiterated RatingHoldN/AView Rating Details
6/21/2016Wells Fargo & CompanyUpgradeMarket Perform -> OutperformN/AView Rating Details
2/10/2016J P Morgan Chase & CoLower Price TargetOverweight$32.00 -> $28.00N/AView Rating Details
2/10/2016Deutsche Bank AGLower Price TargetHold$31.00 -> $24.00N/AView Rating Details
12/9/2015Raymond James Financial, Inc.DowngradeOutperform -> Market PerformN/AView Rating Details
(Data available from 7/21/2015 forward)

Earnings

Earnings History for Catalent (NASDAQ:CTLT)
Earnings by Quarter for Catalent (NASDAQ:CTLT)
Earnings History by Quarter for Catalent (NASDAQ CTLT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/28/2017$0.57N/AView Earnings Details
5/4/2017Q3 2017$0.36$0.38$470.95 million$532.60 millionViewListenView Earnings Details
2/6/2017Q217$0.27$0.27$474.07 million$483.70 millionViewListenView Earnings Details
11/7/2016Q117$0.13$0.16$430.26 million$442.20 millionViewListenView Earnings Details
8/29/2016Q416$0.53$0.52$498.06 million$532.20 millionViewListenView Earnings Details
5/4/2016Q316$0.31$0.20$425.92 million$438.00 millionViewN/AView Earnings Details
2/9/2016Q216$0.34$0.36$441.99 million$454.90 millionViewN/AView Earnings Details
11/3/2015Q116$0.21$0.14$407.80 million$423.00 millionViewN/AView Earnings Details
9/2/2015Q415$0.58$0.60$496.91 million$510.10 millionViewN/AView Earnings Details
5/5/2015Q3 2015$0.43$0.46$453.25 million$446.60 millionViewN/AView Earnings Details
2/11/2015Q215$0.33$0.44$451.40 million$455.80 millionViewN/AView Earnings Details
11/13/2014Q314$0.20$0.13$411.20 million$418.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Catalent (NASDAQ:CTLT)
2017 EPS Consensus Estimate: $1.32
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.12$0.13$0.12
Q2 20173$0.24$0.30$0.26
Q3 20173$0.34$0.37$0.35
Q4 20173$0.55$0.61$0.58
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Catalent (NASDAQ:CTLT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Catalent (NASDAQ:CTLT)
Insider Trades by Quarter for Catalent (NASDAQ:CTLT)
Institutional Ownership by Quarter for Catalent (NASDAQ:CTLT)
Insider Trades by Quarter for Catalent (NASDAQ:CTLT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/25/2017Sharon JohnsonInsiderSell9,160$29.00$265,640.00View SEC Filing  
3/20/2017John R. ChiminskiInsiderSell73,819$28.62$2,112,699.78View SEC Filing  
2/15/2017Donald E. Morel, Jr.DirectorBuy10,000$29.27$292,700.00View SEC Filing  
9/9/2016Blackstone Management AssociatMajor ShareholderSell17,100,705$23.58$403,234,623.90View SEC Filing  
6/9/2016Blackstone Management AssociatMajor ShareholderSell8,785,539$24.51$215,333,560.89View SEC Filing  
5/27/2016Matthew M WalshInsiderSell21,197$28.85$611,533.45View SEC Filing  
8/19/2015John R ChiminskiInsiderSell38,505$33.81$1,301,854.05View SEC Filing  
8/17/2015John R ChiminskiInsiderSell35,550$33.80$1,201,590.00View SEC Filing  
7/20/2015John R ChiminskiInsiderSell33,081$29.40$972,581.40View SEC Filing  
7/6/2015John R ChiminskiInsiderSell33,828$29.34$992,513.52View SEC Filing  
6/11/2015Blackstone Management AssociatMajor ShareholderSell1,844,963$28.13$51,898,809.19View SEC Filing  
6/8/2015Blackstone Management AssociatMajor ShareholderSell12,299,753$28.13$345,992,051.89View SEC Filing  
4/1/2015Scott HoultonInsiderSell16,253$30.61$497,504.33View SEC Filing  
3/27/2015Stephen LeonardInsiderSell31,005$30.13$934,180.65View SEC Filing  
2/17/2015Scott HoultonInsiderSell14,538$27.50$399,795.00View SEC Filing  
2/13/2015Scott HoultonInsiderSell1,400$28.28$39,592.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Catalent (NASDAQ:CTLT)
Latest Headlines for Catalent (NASDAQ:CTLT)
Source:
DateHeadline
americanbankingnews.com logoCatalent Inc (NASDAQ:CTLT) Stock Rating Reaffirmed by Bank of America Corporation
www.americanbankingnews.com - July 21 at 9:30 AM
finance.yahoo.com logoCatalent, Inc. Announces Fourth Quarter and Fiscal Year 2017 Earnings Conference Webcast
finance.yahoo.com - July 19 at 6:47 PM
nasdaq.com logoNoteworthy ETF Inflows: IWO, KITE, MDSO, CTLT - Nasdaq
www.nasdaq.com - July 14 at 3:26 PM
finance.yahoo.com logoCatalent, Inc. breached its 50 day moving average in a Bearish Manner : CTLT-US : July 14, 2017
finance.yahoo.com - July 14 at 3:26 PM
americanbankingnews.com logoFY2017 Earnings Forecast for Catalent Inc Issued By KeyCorp (CTLT)
www.americanbankingnews.com - July 12 at 10:20 AM
americanbankingnews.com logo Analysts Expect Catalent Inc (CTLT) Will Post Quarterly Sales of $543.47 Million
www.americanbankingnews.com - July 8 at 10:30 AM
americanbankingnews.com logo$0.55 EPS Expected for Catalent Inc (CTLT) This Quarter
www.americanbankingnews.com - July 6 at 8:45 AM
americanbankingnews.com logoCatalent Inc (CTLT) Upgraded to Buy at Zacks Investment Research
www.americanbankingnews.com - July 4 at 10:26 PM
finance.yahoo.com logoETFs with exposure to Catalent, Inc. : July 3, 2017
finance.yahoo.com - July 3 at 5:33 PM
americanbankingnews.com logoCatalent Inc (CTLT) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - June 27 at 2:56 PM
finance.yahoo.com logoETFs with exposure to Catalent, Inc. : June 19, 2017
finance.yahoo.com - June 19 at 7:05 PM
finance.yahoo.com logoCatalent, Inc. :CTLT-US: Earnings Analysis: Q3, 2017 By the Numbers : June 16, 2017
finance.yahoo.com - June 16 at 5:18 PM
americanbankingnews.com logoCatalent Inc (CTLT) Expected to Announce Quarterly Sales of $543.47 Million
www.americanbankingnews.com - June 14 at 1:02 PM
americanbankingnews.com logoCatalent Inc (CTLT) Expected to Announce Earnings of $0.56 Per Share
www.americanbankingnews.com - June 12 at 9:27 AM
finance.yahoo.com logoCatalent, Inc. to Present at William Blair & Company’s 37th Annual Growth Stock Conference
finance.yahoo.com - June 6 at 4:49 PM
americanbankingnews.com logoCatalent Inc (CTLT) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - June 2 at 9:00 AM
finance.yahoo.com logoCatalent, Inc. to Present at the Jefferies 2017 Healthcare Conference
finance.yahoo.com - May 25 at 6:14 PM
americanbankingnews.com logoCatalent's (CTLT) "Buy" Rating Reiterated at Bank of America Corp
www.americanbankingnews.com - May 17 at 12:16 PM
americanbankingnews.com logo Analysts Anticipate Catalent Inc (CTLT) Will Post Quarterly Sales of $545.79 Million
www.americanbankingnews.com - May 17 at 9:22 AM
americanbankingnews.com logoFY2019 EPS Estimates for Catalent Inc (CTLT) Increased by Analyst
www.americanbankingnews.com - May 16 at 1:26 PM
americanbankingnews.com logoZacks: Analysts Anticipate Catalent Inc (CTLT) Will Post Earnings of $0.56 Per Share
www.americanbankingnews.com - May 15 at 8:14 PM
finance.yahoo.com logoMedical Stock Bolts Higher On 81% Spike In Earnings
finance.yahoo.com - May 12 at 5:06 PM
americanbankingnews.com logoCatalent Inc (CTLT) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - May 9 at 8:34 PM
nasdaq.com logoCatalent (CTLT) Shows Strength: Stock Adds 9.8% in Session - Nasdaq
www.nasdaq.com - May 9 at 8:00 AM
nasdaq.com logoCatalent Reaches Analyst Target Price
www.nasdaq.com - May 8 at 4:26 PM
americanbankingnews.com logoCatalent Inc (CTLT) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 8 at 11:28 AM
nasdaq.com logoCatalent Inc. (CTLT) Has Spiked To A New High On Q3 Results - Nasdaq
www.nasdaq.com - May 5 at 9:49 PM
fool.com logoHere's Why Catalent Inc. Rose as Much as 20.3% Today
www.fool.com - May 5 at 4:48 PM
finance.yahoo.com logoEdited Transcript of CTLT earnings conference call or presentation 4-May-17 8:45pm GMT
finance.yahoo.com - May 5 at 4:48 PM
finance.yahoo.com logoHere's Why Catalent Inc. Rose as Much as 20.3% Today
finance.yahoo.com - May 5 at 4:48 PM
americanbankingnews.com logoCatalent Inc (CTLT) Rating Increased to Outperform at William Blair
www.americanbankingnews.com - May 5 at 9:29 AM
americanbankingnews.com logoCatalent Inc (CTLT) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS
www.americanbankingnews.com - May 4 at 11:16 PM
seekingalpha.com logoCatalent (CTLT) Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - May 4 at 9:43 PM
finance.yahoo.com logoCatalent, Inc. Reports Third Quarter Fiscal Year 2017 Results
finance.yahoo.com - May 4 at 4:42 PM
americanbankingnews.com logoCatalent (CTLT) Receiving Somewhat Favorable Press Coverage, AlphaOne Reports
www.americanbankingnews.com - May 4 at 3:24 PM
seekingalpha.com logoFamous Dave's: Music To My Ears
seekingalpha.com - May 3 at 4:30 PM
americanbankingnews.com logoCatalent (CTLT) Receives News Sentiment Rating of -0.12
www.americanbankingnews.com - May 1 at 4:30 PM
americanbankingnews.com logoCatalent (CTLT) Earns News Impact Score of 0.09
www.americanbankingnews.com - April 27 at 7:27 PM
americanbankingnews.com logoSharon Johnson Sells 9,160 Shares of Catalent Inc (CTLT) Stock
www.americanbankingnews.com - April 27 at 5:56 PM
finance.yahoo.com logoCatalent, Inc. – Value Analysis (NYSE:CTLT) : April 27, 2017
finance.yahoo.com - April 27 at 5:05 PM
americanbankingnews.com logo$472.58 Million in Sales Expected for Catalent Inc (CTLT) This Quarter
www.americanbankingnews.com - April 27 at 2:01 PM
finance.yahoo.com logoCatalent, Inc. to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference - Yahoo Finance
finance.yahoo.com - April 27 at 1:55 AM
finance.yahoo.com logoCatalent, Inc. breached its 50 day moving average in a Bullish Manner : CTLT-US : April 26, 2017
finance.yahoo.com - April 27 at 1:55 AM
finance.yahoo.com logoCatalent, Inc. to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference
finance.yahoo.com - April 27 at 1:55 AM
americanbankingnews.com logoCatalent Inc (CTLT) Upgraded to "B-" at TheStreet
www.americanbankingnews.com - April 21 at 3:48 PM
americanbankingnews.com logoCatalent (CTLT) Getting Favorable News Coverage, Report Finds
www.americanbankingnews.com - April 21 at 2:16 PM
americanbankingnews.com logoCatalent Inc (CTLT) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - April 20 at 9:43 PM
americanbankingnews.com logoCatalent Inc (CTLT) Cut to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 18 at 7:28 AM
finance.yahoo.com logoCatalent, Inc. Announces Third Quarter Fiscal Year 2017 Earnings Conference Webcast
finance.yahoo.com - April 17 at 4:19 PM
americanbankingnews.com logoCatalent (CTLT) Receiving Somewhat Negative News Coverage, AlphaOne Reports
www.americanbankingnews.com - April 17 at 2:30 PM

Social

Chart

Catalent (CTLT) Chart for Friday, July, 21, 2017

This page was last updated on 7/21/2017 by MarketBeat.com Staff